Letter from our CEO: The New Curebase and Our Path Ahead
Articles

Letter from our CEO: The New Curebase and Our Path Ahead

Stay updated with the latest developments at Curebase in a letter from our CEO.

Categories
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Curebase thinks the future of clinical testing is decentralized and raises $40M to prove it
News

Curebase thinks the future of clinical testing is decentralized and raises $40M to prove it

Curebase attracts Gilead as backer in $40M financing to expand business
News

Curebase attracts Gilead as backer in $40M financing to expand business

Challenges & Solutions: Designing ePRO and eConsent for Pediatric Trials Webinar
Webinar

Challenges & Solutions: Designing ePRO and eConsent for Pediatric Trials Webinar

🎉 Curebase Feature Launch: Pediatric Studies Made Easier with Multi-User Accounts
Feature Highlights

🎉 Curebase Feature Launch: Pediatric Studies Made Easier with Multi-User Accounts

Letter from our CEO: The New Curebase and Our Path Ahead
Articles

Letter from our CEO: The New Curebase and Our Path Ahead

Navigation

HomeePRO/eCOAeConsentUnified Participant ExperienceAbout UsResourcesContact Us

Contact

548 Market St PMB 86319
San Francisco, CA 94104-5401
[email protected]

Curebase © 2024. All Rights Reserved
Privacy Policy
|
Terms & Conditions